Comparing Transperineal to Transrectal MRI-US Fusion Prostate Biopsy

Prostate Biopsy Clinical Trial

Official title: A Prospective Cohort Study Comparing Transperineal to Transrectal MRI-US Fusion Prostate Biopsy

Status Recruiting

Clinical Trial Summary

This will be a prospective cohort trial that compares transperineal to transrectal MRI-US fusion prostate biopsy

Clinical Trial Description

This will be a prospective cohort trial that compares transperineal to transrectal MRI-US fusion prostate biopsy among men. The target population are males that are schedule to undergo MRI-US Fusion prostate biopsy and have an MRI of the prostate. All the pathological samples would be conducted from the area in the prostate that was found as suspicious of malignancy by previous MRI imaging, and defined as region of interest (ROI).

First the prostate biopsy will be preformed in a transperineal approach; Then a transrectal approach would be used to sample a few more cores.

The primary endpoint will be To compare the detection rate for clinically significant prostate cancer between transperineal vs transrectal mp-MRI-fusion/TRUS biopsies. Additionally, the study aims to determine the accuracy of prostate cancer detection in transperineal vs transrectal mp-MRI-fusion/TRUS biopsies. ;

Related Conditions & MeSH terms

• Prostate Biopsy

• NCT number: NCT03413137
• Study type: Interventional
• Source: Rabin Medical Center
• Contact: Sivan Sela, B.Sc
• Phone: +972(0)3-9376553
• Email: Sivanto1@clalit.org.il
• Status: Recruiting
• Phase: N/A
• Start date: December 11, 2017
• Completion date: October 2019